methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate CAS:313535-84-1

Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate plays a pivotal role in the synthesis of pharmaceuticals, serving as a key precursor for a wide range of bioactive compounds. Its quinazoline scaffold is a common structural motif found in numerous drugs, including anticancer agents, antihistamines, and kinase inhibitors. By leveraging the versatility of this compound, chemists can access a plethora of synthetic pathways to create novel drug candidates with potential therapeutic benefits. Furthermore, its incorporation into drug discovery efforts enables the modification of the quinazoline framework to generate derivatives with optimized pharmacological properties, such as improved potency and selectivity. Additionally, this compound is utilized in academic research and industrial settings to explore new chemical entities with promising pharmacological profiles. The reliability and consistency of methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate make it an indispensable tool in the pharmaceutical industry, facilitating the efficient synthesis of complex molecules while ensuring reproducible results. As a foundational component in medicinal chemistry, it empowers scientists to expand the chemical space of potential drug candidates and advance the development of innovative therapies for various medical conditions.